HomeGeneral NewsAI drug discovery: Oxford’s innovations in oncology

AI drug discovery: Oxford’s innovations in oncology

January 31, 2025

- Advertisement -

Pioneering AI in cancer drug discovery with novel therapeutics and expansion plans for 2025.

Oxford Drug Design has established itself as a leader in AI-driven drug discovery, particularly in oncology.

Alan Roth, the Chief Executive Officer at Oxford Drug Design, highlighted the urgent need for…

- Advertisment -